Virtual Presentation

Multiple Myeloma

Source: Clinical Issues and Future Directions in Hematologic Malignancies

Multiple Myeloma


Faculty:

  • Amitabha Mazumder, MD

CME CREDIT INFORMATION

Release Date: 04/15/08

Expiration Date: 04/14/09


Physicians: maximum of 0.75 AMA PRA Category 1 Credit(s)™

Registered Nurses: 0.8 Nursing CE credit

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss frontline induction therapy strategies for patients with newly diagnosed multiple myeloma
  • Cite cytogenetic and hematologic factors prognostic for outcomes in the treatment of patients with multiple myeloma
  • Describe recent clinical trial results regarding frontline therapy for elderly myeloma patients and others who are not candidates for autologous stem cell transplantation
  • List novel agents emerging in the setting of multiple myeloma

CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grants provided by:

Educational grants support only the CME-certified components of this program.